Lupin has incorporated a wholly-owned subsidiary in the USA under the name ‘Lupin Oncology Inc.’ (LOI). This wholly owned subsidiary will be engaged in development/co-development and commercialization of multiple oncology products globally. LOI will be pursuing partners, financial sponsors and perform such other acts as may be necessary.
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India.